• OPEN AN ACCOUNT
Indian Indices
Nifty
26,202.95 -12.60
(-0.05%)
Sensex
85,997.70 291.03
( 0.34%)
Bank Nifty
59,752.70 15.40
( 0.03%)
Nifty IT
37,405.50 -40.80
( -0.11%)
Global Indices
Nasdaq
47,737.43 289.30
(0.61%)
Dow Jones
6,869.48 35.87
(0.52%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,721.02 27.09
(0.28%)
Forex
USD-INR
89.30 0.10
(0.11%)
EUR-INR
103.54 0.22
(0.21%)
GBP-INR
118.23 0.49
(0.41%)
JPY-INR
0.57 0.00
(0.17%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
126.25
28.18
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

BHEL gains as Q2 PAT skyrockets 253% YoY to Rs 375 cr
Oct 30,2025

Revenue from operations rose 14.06% year on year to Rs 7,511.80 crore in the quarter ended 30 September 2025.

Profit before tax (PBT) stood at Rs 499.23 crore, up 253.01%, compared with Rs 141.42 crore posted in same quarter last year.

Total expenses increased 9.60% YoY to Rs 7,201.54 crore in the September 2025 quarter. The cost of materials & services stood at Rs 5,741.38 crore (up 19.89%), while employee benefits expenses were at Rs 1,479.17 crore (up 0.87% YoY) during the period under review.

On the segmental front, revenue from the power business stood at Rs 5,675.64 crore (up 12.87% YoY) and revenue from industry stood at Rs 1,836.16 crore (up 18.01% YoY) during the period under review.

Bharat Heavy Electricals (BHEL) is an integrated power plant equipment manufacturer, engaged in the design, engineering, manufacturing, erection, testing, commissioning, and servicing of a diverse range of products and systems. The company caters to key sectors of the Indian economy, including power, transmission, industry, transportation, renewable energy, oil & gas, and defence. BHEL is the flagship engineering and manufacturing enterprise of India and is owned and operated by the Government of India.